As an important partner to the forensic community, Cayman Chemical is dedicated to the research, development, and production of a wide variety of research/analytical tools.  It is our responsibility to monitor current trends and rapidly develop reference standards necessary for the early detection of NPS.  Listen as Holly Pierzynski, Cayman’s Manager of Forensic Novel Psychoactive Substance Research, discusses recent developments among several popular drug classes including new analogues that have appeared recently on the grey marketplace and reviews the emergence of synthetic precursors being sold for the non-legitimate production of opioids, benzodiazepines, and synthetic cannabinoids. 

Presented as part of the 2024 Current Trends in Seized Drug Analysis Symposium.